
Sign up to save your podcasts
Or


Send a Text Message. Please include your name and email so we can answer you! Please note, this does not subscribe you to our email list, it's just to answer if you have a questions for us.
Weight loss medications are evolving at lightning speed. But once you start digging online, it’s easy to feel unsure about what’s real, what’s safe, and what your options actually are if a medication stops working.
In this episode, I walk you through what’s genuinely on the horizon between 2026–2028, using the clinical data we have right now. We’re talking higher-dose oral Wegovy, more affordable non-refrigerated options, and the triple agonist many people are waiting for, with nearly 29% average weight loss.
Tune in to find out how these medications work, what the research is showing so far, and why this pipeline offers real hope for anyone managing obesity as a chronic disease.
References
Timeline of upcoming obesity medications
Coloring recommendations:
Alcohol Markers
Coloring books
Season 2 of The Obesity Guide: Behind the Curtain Podcast
Get my free Podcast Roadmap—a simple guide to help you find the episodes that matter most to your journey.
Audio Stamps
00:30 – The importance of building a dopamine menu with non-food hobbies to manage obesity long-term.
06:08 – Staying open to new treatments and pivoting strategies in managing a chronic, lifelong disease.
07:48 – Oral Wegovy coming early 2026 with improved results and affordability.
10:00 – Higher-dose Wegovy subq arriving with 21% average weight loss.
11:50 – Orforglipron: a new non-refrigerated oral GLP-1 option.
12:40 – CagriSema combines semaglutide with amylin for enhanced results.
14:20 – Retatrutide overview and warnings about unregulated versions.
15:
All of the information on this podcast is for general informational purposes only. Please talk to your physician and medical team about what is right for you. No medical advice is being on this podcast.
If you live in Indiana or Illinois and want to work with doctor Matthea Rentea, you can find out more on www.RenteaClinic.com
Get my free Podcast Roadmap—a simple guide to help you find the episodes that matter most to your journey. Whether you're on GLP-1s, navigating plateaus, or just starting out, there's something here for you.
Support the show
By Matthea Rentea MD4.9
261261 ratings
Send a Text Message. Please include your name and email so we can answer you! Please note, this does not subscribe you to our email list, it's just to answer if you have a questions for us.
Weight loss medications are evolving at lightning speed. But once you start digging online, it’s easy to feel unsure about what’s real, what’s safe, and what your options actually are if a medication stops working.
In this episode, I walk you through what’s genuinely on the horizon between 2026–2028, using the clinical data we have right now. We’re talking higher-dose oral Wegovy, more affordable non-refrigerated options, and the triple agonist many people are waiting for, with nearly 29% average weight loss.
Tune in to find out how these medications work, what the research is showing so far, and why this pipeline offers real hope for anyone managing obesity as a chronic disease.
References
Timeline of upcoming obesity medications
Coloring recommendations:
Alcohol Markers
Coloring books
Season 2 of The Obesity Guide: Behind the Curtain Podcast
Get my free Podcast Roadmap—a simple guide to help you find the episodes that matter most to your journey.
Audio Stamps
00:30 – The importance of building a dopamine menu with non-food hobbies to manage obesity long-term.
06:08 – Staying open to new treatments and pivoting strategies in managing a chronic, lifelong disease.
07:48 – Oral Wegovy coming early 2026 with improved results and affordability.
10:00 – Higher-dose Wegovy subq arriving with 21% average weight loss.
11:50 – Orforglipron: a new non-refrigerated oral GLP-1 option.
12:40 – CagriSema combines semaglutide with amylin for enhanced results.
14:20 – Retatrutide overview and warnings about unregulated versions.
15:
All of the information on this podcast is for general informational purposes only. Please talk to your physician and medical team about what is right for you. No medical advice is being on this podcast.
If you live in Indiana or Illinois and want to work with doctor Matthea Rentea, you can find out more on www.RenteaClinic.com
Get my free Podcast Roadmap—a simple guide to help you find the episodes that matter most to your journey. Whether you're on GLP-1s, navigating plateaus, or just starting out, there's something here for you.
Support the show

2,198 Listeners

7,533 Listeners

116 Listeners

1,690 Listeners

420 Listeners

1,268 Listeners

215 Listeners

364 Listeners

36 Listeners

106 Listeners

70 Listeners

172 Listeners

44 Listeners

153 Listeners

42 Listeners